186 related articles for article (PubMed ID: 29603139)
21. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
22. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
[TBL] [Abstract][Full Text] [Related]
23. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
24. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
[TBL] [Abstract][Full Text] [Related]
25. Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion.
Dunn S; Panjwani D; Gupta M; Meaney C; Morgan R; Feuerstein E
Contraception; 2015 Sep; 92(3):220-6. PubMed ID: 26068140
[TBL] [Abstract][Full Text] [Related]
26. Use of an at-home multilevel pregnancy test and an automated call-in system to follow-up the outcome of medical abortion.
Anger H; Dabash R; Peña M; Coutiño D; Bousiéguez M; Sanhueza P; Winikoff B
Int J Gynaecol Obstet; 2019 Jan; 144(1):97-102. PubMed ID: 30221366
[TBL] [Abstract][Full Text] [Related]
27. Provision of medical abortion using telemedicine in Brazil.
Gomperts R; van der Vleuten K; Jelinska K; da Costa CV; Gemzell-Danielsson K; Kleiverda G
Contraception; 2014 Feb; 89(2):129-33. PubMed ID: 24314910
[TBL] [Abstract][Full Text] [Related]
28. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
[TBL] [Abstract][Full Text] [Related]
29. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
[TBL] [Abstract][Full Text] [Related]
30. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
Chong E; Tsereteli T; Nguyen NN; Winikoff B
Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
Li YT; Hsieh JC; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Tang HH; Kuo TC
Taiwan J Obstet Gynecol; 2011 Mar; 50(1):11-4. PubMed ID: 21482367
[TBL] [Abstract][Full Text] [Related]
33. An effective regimen for early medical abortion: a report of 2000 consecutive cases.
Ashok PW; Penney GC; Flett GM; Templeton A
Hum Reprod; 1998 Oct; 13(1O):2962-5. PubMed ID: 9804263
[TBL] [Abstract][Full Text] [Related]
34. Building Bridges: A Case for Community Health Worker Provision of Misoprostol-Only Abortion in the First Trimester.
Tebbets C; Santana D; Ros Silvestre J; Redwine D
J Womens Health (Larchmt); 2018 Mar; 27(3):311-316. PubMed ID: 29040004
[TBL] [Abstract][Full Text] [Related]
35. The introduction of first trimester medical abortion in Armenia.
Louie KS; Chong E; Tsereteli T; Avagyan G; Vardanyan S; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):56-66. PubMed ID: 25702069
[TBL] [Abstract][Full Text] [Related]
36. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
38. Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits.
Tsereteli N; Mamatsashvili L; Tsertsvadze G; Tsereteli T; Platais I
Eur J Contracept Reprod Health Care; 2023 Apr; 28(2):141-146. PubMed ID: 36751958
[TBL] [Abstract][Full Text] [Related]
39. Medication Abortion With Pharmacist Dispensing of Mifepristone.
Grossman D; Baba CF; Kaller S; Biggs MA; Raifman S; Gurazada T; Rafie S; Averbach S; Meckstroth KR; Micks EA; Berry E; Raine-Bennett TR; Creinin MD
Obstet Gynecol; 2021 Apr; 137(4):613-622. PubMed ID: 33706339
[TBL] [Abstract][Full Text] [Related]
40. Early pregnancy termination with mifepristone and misoprostol in Norway.
Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
